Contemporary outcomes for ulcerative colitis inpatients admitted to pediatric hospitals in the United Kingdom

Inflammatory Bowel Diseases

Volumn 19, Issue 7, 2013, Pages 1434-1440

  Russell, Richard K ^a   Protheroe, Aimee ^b   Roughton, Michael ^b   Croft, Nick M ^c   Stephen Murphy, M ^d   Spray, Christine ^e   Rodrigues, Astor F ^f   Wilson, David C ^g   Puntis, John ^h   Cosgrove, Mike ⁱ   Tamok, Andras ^j   Rao, Prithviraj ^k   Down, Calvin ^b   Arnott, Ian D R ^g   Mitton, Sally G ^l  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h LEEDS GENERAL INFIRMARY   (United Kingdom)

ⁱ SINGLETON HOSPITAL   (United Kingdom)

^j Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

^k SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^l ST GEORGE S HOSPITAL   (United Kingdom)

more..

Author keywords

Children; Corticosteroids; Cyclosporin; Infliximab; Ulcerative colitis

Indexed keywords

CYCLOSPORIN A; HYDROCORTISONE; INFLIXIMAB; MEPREDNISONE; PREDNISOLONE;

ADOLESCENT; ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE; COMPARATIVE STUDY; ELECTIVE SURGERY; EMERGENCY CARE; FECES CULTURE; FEMALE; HEPARINIZATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOSIS; TOXIC MEGACOLON; TREATMENT RESPONSE; ULCERATIVE COLITIS; UNITED KINGDOM;

ADOLESCENT; CELL CULTURE TECHNIQUES; CHILD; COLITIS, ULCERATIVE; FECES; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HOSPITALIZATION; HUMANS; INPATIENTS; LENGTH OF STAY; MALE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84879107348     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e31828133d6     Document Type: Article

References (24)

1. Henderson P, Hansen R, Cameron FL, et al. The rising incidence of paediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis. 2012;18:999-1005.
2. Benchimol EI, Fortinsky KJ, Gozdyra P, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17:423-439.
3. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54.
4. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423-432.
5. Turner D, Travis SP, Griffiths AM, et al. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol. 2011;106:574-588.
6. Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135:1114-1122.
7. Turner D, Griffiths AM. Acute severe ulcerative colitis in children: a systematic review. Inflamm Bowel Dis. 2011;17:440-449.
8. Turner D, Walsh CM, Steinhart AH, et al. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a metaregression. Clin Gastroenterol Hepatol. 2007;5:103-110.
9. Turner D, Walsh CM, Benchimol EI, et al. Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy. Gut. 2008;57:331-338.
10. Turner D, Mack D, Leleiko N, et al. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology. 2010;138:2282-2291.
11. Benchimol EI, Turner D, Mann EH, et al. Toxic megacolon in children with inflammatory bowel disease: clinical and radiographic characteristics. Am J Gastroenterol. 2008;103:1524-1531.
12. Barclay AR, Keightley JM, Horrocks I, et al. Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:677-683.
13. Lazzerini M, Bramuzzo M, Maschio M, et al. Thromboembolism in pediatric inflammatory bowel disease: systematic review. Inflamm Bowel Dis. 2011;17:2174-2183.
14. Colletti RB, Baldassano RN, Milov DE, et al. Variation in care in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2009;49:297-303.
15. Cohen RD, Yu AP, Wu EQ, et al. Systematic review: costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther. 2010;31:693-707.
16. UK Inflammatory Bowel Disease Audit Steering Group. UK IBD Audit 2008 (Executive Summary). 2009. Royal College of Physicians of London.
17. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314-1321.
18. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2009;104:2080-2088.
19. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135:1907-1913.
20. Wilson D, Thomas A, Croft N, et al. Systematic Review of the Evidence Base for the Medical Treatment of Paediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2010;50(Suppl 1):S14-S34.
21. Crandall WV, Margolis PA, Kappelman MD, et al. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics. 2012;129:e1030-e1041.
22. Turner D, Hyams J, Markowitz J, et al. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis. 2009;15:1218-1223.
23. Kappelman MD, Horvath-Puho E, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011;60:937-943.
24. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657-663.